Market By Application, Modality And Country | Forecast 2019-2028
Triton Market Research, in its report on the extra corporeal membrane oxygenation (ECMO) system market in the Asia-Pacific region, has determined that it will grow at a CAGR of 5.11% in the forecasted period 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in the Asia-Pacific extra corporeal membrane oxygenation (ECMO) system market are:
• South Korea
• China
• ASEAN countries
• Japan
• India
• Australia & New Zealand
• Rest of APAC
The extra corporeal membrane oxygenation (ECMO) system market in China is experiencing a sustainable growth owing to the large patient population and rising healthcare expenditure in the country. There is a high prevalence of respiratory and cardiac disorder patients in the country. The growing public awareness regarding ECMO systems and the increasing occurrence of chronic respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma are creating growth opportunities for the studied market in the upcoming years.
It is reported that there was an upsurge of 38.8% in ECMO cases in 2020 in the country. There is also a considerable increase in the number of ECMO centers that have sprawled up. Also, those centers with over 20 ECMO cases per year had a favorable in-hospital survival rate than the centers with fewer cases. Therefore, the growing ECLS cases and centers in China are resulting in the development of the studied market in the country.
The increasing medical expenditure, alarming rise in cardiovascular diseases, expanding geriatric population and the easy availability of state-of-the-art medical facilities, are majorly driving the growth of the ECMO market in Japan. There has been a considerable increase in the prevalence of chronic respiratory diseases like bronchial asthma and chronic obstructive pulmonary disease in the country. This is also aiding the market growth.
Terumo Corporation is a company engaged in manufacturing and distributing medical products and equipment. The company operates in three major business segments, namely cardiac & vascular company, general hospital company and blood management company. The new CAPIOX FX Advance Oxygenator and CAPIOX RX25 Membrane Oxygenator are products provided by the company. It is headquartered in Tokyo, Japan.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1.MARKET DEFINITION
2.2.PORTER’S FIVE FORCES MODEL
2.2.1.THREAT OF NEW ENTRANTS
2.2.2.THREAT OF SUBSTITUTE PRODUCTS
2.2.3.BARGAINING POWER OF BUYERS
2.2.4.BARGAINING POWER OF SUPPLIERS
2.2.5.COMPETITIVE RIVALRY
2.3.IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
2.4.MARKET ATTRACTIVENESS INDEX
2.5.VENDOR SCORECARD
2.6.KEY INSIGHTS
2.7.MARKET DRIVERS
2.7.1.RISING POPULARITY OF ECMO TECHNOLOGY
2.7.2.INCREASING PREVALENCE OF CHRONIC DISORDERS
2.8.MARKET RESTRAINTS
2.8.1.SIGNIFICANT COST OF ECMO SYSTEMS
2.8.2.EXISTENCE OF ALTERNATIVE TECHNIQUES
2.9.MARKET OPPORTUNITIES
2.9.1.GROWING AWARENESS REGARDING APPLICATIONS OF ECMO SYSTEMS
2.9.2.ADVANCEMENT IN TECHNOLOGY
2.10.MARKET CHALLENGES
2.10.1.LACK OF SPECIALIZED SKILLS FOR OPERATION
2.10.2.RISKS ASSOCIATED WITH ECMO PROCEDURES
3. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET OUTLOOK - BY APPLICATION
3.1.RESPIRATORY
3.2.CARDIAC
3.3.EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
4. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET OUTLOOK - BY MODALITY
4.1.VENO-VENOUS
4.2.VENO-ARTERIAL
4.3.OTHER MODALITIES
5. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET – ASIA-PACIFIC
5.1.CHINA
5.2.JAPAN
5.3.INDIA
5.4.AUSTRALIA & NEW ZEALAND
5.5.SOUTH KOREA
5.6.ASEAN COUNTRIES
5.7.REST OF ASIA-PACIFIC
6. COMPANY PROFILES
6.1.HEMOVENT GMBH
6.2.LIVANOVA PLC
6.3.MICROPORT SCIENTIFIC CORPORATION
6.4.TERUMO MEDICAL CORPORATION
6.5.ELSIUS BIOMEDICAL INC
6.6.ABBOTT LABORATORIES
6.7.ALUNG TECHNOLOGIES INC
6.8.EUROSETS
6.9.SPECTRUM MEDICAL
6.10.XENIOS AG (FRESENIUS SE & CO KGAA)
6.11.MEDTRONIC PLC
6.12.GETINGE AB
6.13.NIPRO CORPORATION
6.14.ORIGEN BIOMEDICAL INC
7. RESEARCH METHODOLOGY & SCOPE
7.1.RESEARCH SCOPE & DELIVERABLES
7.1.1.OBJECTIVES OF STUDY
7.1.2.SCOPE OF STUDY
7.2.SOURCES OF DATA
7.2.1.PRIMARY DATA SOURCES
7.2.2.SECONDARY DATA SOURCES
7.3.RESEARCH METHODOLOGY
7.3.1.EVALUATION OF PROPOSED MARKET
7.3.2.IDENTIFICATION OF DATA SOURCES
7.3.3.ASSESSMENT OF MARKET DETERMINANTS
7.3.4.DATA COLLECTION
7.3.5.DATA VALIDATION & ANALYSIS
TABLE 1 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, 2019-2028 ($ MILLION)
TABLE 4 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, 2019-2028 ($ MILLION)
TABLE 5 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
FIGURE 1 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 2 LIST OF CHRONIC DISEASES
FIGURE 3 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 ($ MILLION)
FIGURE 4 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 ($ MILLION)
FIGURE 5 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 ($ MILLION)
FIGURE 6 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 ($ MILLION)
FIGURE 7 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 ($ MILLION)
FIGURE 8 ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 ($ MILLION)
FIGURE 9 CHINA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 10 JAPAN EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 11 INDIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 12 AUSTRALIA & NEW ZEALAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 13 SOUTH KOREA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 14 ASEAN COUNTRIES EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 15 REST OF ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)